Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,170,084
+$56,579 QoQ
Shares Held
55,700
-2.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#382
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. AMGN ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
This page
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,170,084 | 55,700 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $20,113,505 | 57,165 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,605,869 | 59,900 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $17,665,720 | 62,600 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $17,562,309 | 62,900 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $20,577,877 | 66,050 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,554,104 | 67,350 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $19,960,909 | 61,950 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,053,681 | 51,380 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $14,618,312 | 51,415 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $14,804,228 | 51,400 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $14,392,098 | 53,550 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $12,037,924 | 54,220 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $13,235,812 | 54,750 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,307,314 | 54,475 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,205,410 | 54,150 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,119,709 | 53,924 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $13,039,901 | 53,924 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $12,131,282 | 53,924 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $11,466,938 | 53,924 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,186,631 | 54,099 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $13,460,372 | 54,099 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $12,300,720 | 53,500 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $13,597,560 | 53,500 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $12,701,061 | 53,850 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $11,028,512 | 54,400 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||